S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 26.68 CNY -3.75% Market Closed
Market Cap: 17.7B CNY
Have any thoughts about
Shandong Pharmaceutical Glass Co Ltd?
Write Note

Net Margin
Shandong Pharmaceutical Glass Co Ltd

17.2%
Current
15%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.2%
=
Net Income
882m
/
Revenue
5.1B

Net Margin Across Competitors

Country CN
Market Cap 17.7B CNY
Net Margin
17%
Country JP
Market Cap 6.8T JPY
Net Margin
24%
Country CH
Market Cap 37.4B CHF
Net Margin
12%
Country DK
Market Cap 179.5B DKK
Net Margin
19%
Country US
Market Cap 15.8B USD
Net Margin
11%
Country CN
Market Cap 52B CNY
Net Margin
42%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country KR
Market Cap 9.1T KRW
Net Margin
-358%
Country US
Market Cap 6.2B USD
Net Margin
29%
Country US
Market Cap 5.7B USD
Net Margin
9%
Country UK
Market Cap 4.5B GBP
Net Margin
7%
No Stocks Found

Shandong Pharmaceutical Glass Co Ltd
Glance View

Market Cap
17.7B CNY
Industry
Health Care

In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.

Intrinsic Value
45.92 CNY
Undervaluation 42%
Intrinsic Value
Price
S

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.2%
=
Net Income
882m
/
Revenue
5.1B
What is the Net Margin of Shandong Pharmaceutical Glass Co Ltd?

Based on Shandong Pharmaceutical Glass Co Ltd's most recent financial statements, the company has Net Margin of 17.2%.